KNSA logo

Kiniksa Pharmaceuticals (KNSA) EBIT

Annual EBIT

-$25.20 M
-$34.97 M-357.81%

December 31, 2023

Summary

Performance

1-Year Change

-357.81%

3-Year Change

+83.99%

5-Year Change

+76.7%

15-Year Change

+61.47%

KNSA EBIT Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

50.48%
KNSA annual earnings before interest & taxes is higher than 50.48% of companies in Healthcare sector

High & Low

All-time High

$9.77 M
KNSA annual earnings before interest & taxes is currently -357.81% below its historical high of $9.77 million

3-Year Low

-$156.64 M

Earnings dates

Last Annual Earnings Report Date

Dec 31, 2023
KNSA previous annual earnings announcement was published on Dec 31, 2023

Next Annual Earnings Report Date

Feb 28, 2025
KNSA next annual earnings announcement is scheduled for Feb 28, 2025

OtherKNSAprofitabilitymetrics:

Annual Revenue

$270.26 M
KNSA annual revenue is $270.26 million

Annual Net Income

$14.08 M
KNSA annual net profit is $14.08 million

Annual EBITDA

-$25.20 M
KNSA annual EBITDA is -$25.20 million

Annual EPS

$0.20
KNSA annual earnings per share is $0.20

Quarterly EBIT

-$9.66 M
-$9.54 M-8154.70%

September 30, 2024

Summary

Performance

3-Month Change

-8154.7%

1-Year Change

+11.61%

3-Year Change

+68.51%

5-Year Change

+68.28%

KNSA Quarterly EBIT Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

39.88%
KNSA quarterly earnings before interest & taxes is higher than 39.88% of companies in Healthcare sector

High & Low

All-time High

$46.41 M
KNSA quarterly earnings before interest & taxes is currently -120.81% below its historical high of $46.41 million

3-Year Low

-$36.13 M

Earnings dates

Last Quarterly Earnings Report Date

Sep 30, 2024
KNSA previous earnings announcement was published on Sep 30, 2024

Next Quarterly Earnings Report Date

Feb 28, 2025
KNSA next earnings announcement is scheduled for Feb 28, 2025

OtherKNSAprofitabilitymetrics:

Quarterly Revenue

$112.21 M
KNSA quarterly revenue is $112.21 million

Quarterly Net Income

-$12.69 M
KNSA quarterly net profit is -$12.69 million

Quarterly EBITDA

-$9.26 M
KNSA quarterly EBITDA is -$9.26 million

Quarterly EPS

-$0.18
KNSA quarterly earnings per share is -$0.18

TTM EBIT

-$26.24 M
+$1.27 M+4.61%

September 30, 2024

Summary

Performance

3-Month Change

+4.61%

1-Year Change

-36.43%

3-Year Change

+84.87%

5-Year Change

+84.56%

KNSA TTM EBIT Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

48.61%
KNSA TTM earnings before interest & taxes is higher than 48.61% of companies in Healthcare sector

High & Low

All-time High

$38.11 M
KNSA TTM earnings before interest & taxes is currently -168.84% below its historical high of $38.11 million

3-Year Low

-$156.64 M

Earnings dates

Last Quarterly Earnings Report Date

Sep 30, 2024
KNSA previous earnings announcement was published on Sep 30, 2024

Next Quarterly Earnings Report Date

Feb 28, 2025
KNSA next earnings announcement is scheduled for Feb 28, 2025

OtherKNSAprofitabilitymetrics:

TTM Revenue

$384.10 M
KNSA TTM revenue is $384.10 million

TTM Net Income

-$9.07 M
KNSA TTM net profit is -$9.07 million

TTM EBITDA

-$24.40 M
KNSA TTM EBITDA is -$24.40 million

TTM EPS

-$0.14
KNSA TTM earnings per share is -$0.14

EBIT Formula

EBIT = Revenue − COGS − Operating Expenses

Annual EBIT

-$25.20 M
KNSA annual earnings before interest & taxes is -$25.20 million

Annual Revenue

$270.26 M
KNSA annual revenue is $270.26 million

Annual Cost Of Goods Sold

$33.41 M
KNSA annual cost of goods sold is $33.41 million

Annual Operating Expenses

$205.52 M
KNSA annual total operating expenses is $205.52 million

KNSA EBIT Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year-357.8%+11.6%-36.4%
3 y3 years+84.0%+68.5%+84.9%
5 y5 years+76.7%+68.3%+84.6%

KNSA EBIT Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-year-357.8%+83.9%-120.8%+73.3%-168.8%+83.3%
5 y5-year-357.8%+85.2%-120.8%+81.7%-168.8%+85.9%
alltimeall time-357.8%+85.2%-120.8%+85.7%-168.8%+85.9%

Kiniksa Pharmaceuticals EBIT History

DateAnnualQuarterlyTTM
Sep 2024
-
-$9.66 M(+8154.7%)
-$26.24 M(-4.6%)
Jun 2024
-
-$117.00 K(-99.3%)
-$27.50 M(-9.9%)
Mar 2024
-
-$16.54 M(<-9900.0%)
-$30.54 M(+21.2%)
Dec 2023
-$25.20 M(-357.8%)
$81.00 K(-100.7%)
-$25.20 M(+31.0%)
Sep 2023
-
-$10.93 M(+246.4%)
-$19.23 M(-150.5%)
Jun 2023
-
-$3.15 M(-71.8%)
$38.11 M(+74.1%)
Mar 2023
-
-$11.20 M(-285.1%)
$21.90 M(+124.0%)
Dec 2022
$9.77 M(-106.2%)
$6.05 M(-87.0%)
$9.77 M(-130.2%)
Sep 2022
-
$46.41 M(-339.6%)
-$32.41 M(-70.4%)
Jun 2022
-
-$19.37 M(-16.9%)
-$109.48 M(-16.2%)
Mar 2022
-
-$23.32 M(-35.5%)
-$130.67 M(-16.6%)
Dec 2021
-$156.64 M(-0.5%)
-$36.13 M(+17.8%)
-$156.64 M(-9.7%)
Sep 2021
-
-$30.67 M(-24.4%)
-$173.40 M(-6.7%)
Jun 2021
-
-$40.55 M(-17.7%)
-$185.95 M(+4.9%)
Mar 2021
-
-$49.28 M(-6.8%)
-$177.26 M(+12.6%)
Dec 2020
-$157.36 M
-$52.90 M(+22.4%)
-$157.36 M(+14.8%)
DateAnnualQuarterlyTTM
Sep 2020
-
-$43.22 M(+35.6%)
-$137.05 M(+10.3%)
Jun 2020
-
-$31.86 M(+8.4%)
-$124.27 M(-5.6%)
Mar 2020
-
-$29.39 M(-9.8%)
-$131.70 M(-22.5%)
Dec 2019
-$169.96 M(+57.1%)
-$32.58 M(+7.0%)
-$169.96 M(-6.4%)
Sep 2019
-
-$30.45 M(-22.5%)
-$181.52 M(+2.4%)
Jun 2019
-
-$39.29 M(-41.9%)
-$177.23 M(+11.1%)
Mar 2019
-
-$67.65 M(+53.3%)
-$159.47 M(+47.4%)
Dec 2018
-$108.16 M(+65.4%)
-$44.13 M(+68.7%)
-$108.16 M(+11.8%)
Sep 2018
-
-$26.16 M(+21.5%)
-$96.74 M(+11.4%)
Jun 2018
-
-$21.53 M(+31.7%)
-$86.83 M(+13.2%)
Mar 2018
-
-$16.34 M(-50.0%)
-$76.69 M(+17.3%)
Dec 2017
-$65.40 M(+172.5%)
-$32.71 M(+101.3%)
-$65.40 M(+100.1%)
Sep 2017
-
-$16.25 M(+42.6%)
-$32.69 M(+98.8%)
Jun 2017
-
-$11.39 M(+125.7%)
-$16.44 M(+225.7%)
Mar 2017
-
-$5.05 M
-$5.05 M
Dec 2016
-$24.00 M
-
-

FAQ

  • What is Kiniksa Pharmaceuticals annual earnings before interest & taxes?
  • What is the all time high annual EBIT for Kiniksa Pharmaceuticals?
  • What is Kiniksa Pharmaceuticals annual EBIT year-on-year change?
  • What is Kiniksa Pharmaceuticals quarterly earnings before interest & taxes?
  • What is the all time high quarterly EBIT for Kiniksa Pharmaceuticals?
  • What is Kiniksa Pharmaceuticals quarterly EBIT year-on-year change?
  • What is Kiniksa Pharmaceuticals TTM earnings before interest & taxes?
  • What is the all time high TTM EBIT for Kiniksa Pharmaceuticals?
  • What is Kiniksa Pharmaceuticals TTM EBIT year-on-year change?

What is Kiniksa Pharmaceuticals annual earnings before interest & taxes?

The current annual EBIT of KNSA is -$25.20 M

What is the all time high annual EBIT for Kiniksa Pharmaceuticals?

Kiniksa Pharmaceuticals all-time high annual earnings before interest & taxes is $9.77 M

What is Kiniksa Pharmaceuticals annual EBIT year-on-year change?

Over the past year, KNSA annual earnings before interest & taxes has changed by -$34.97 M (-357.81%)

What is Kiniksa Pharmaceuticals quarterly earnings before interest & taxes?

The current quarterly EBIT of KNSA is -$9.66 M

What is the all time high quarterly EBIT for Kiniksa Pharmaceuticals?

Kiniksa Pharmaceuticals all-time high quarterly earnings before interest & taxes is $46.41 M

What is Kiniksa Pharmaceuticals quarterly EBIT year-on-year change?

Over the past year, KNSA quarterly earnings before interest & taxes has changed by +$1.27 M (+11.61%)

What is Kiniksa Pharmaceuticals TTM earnings before interest & taxes?

The current TTM EBIT of KNSA is -$26.24 M

What is the all time high TTM EBIT for Kiniksa Pharmaceuticals?

Kiniksa Pharmaceuticals all-time high TTM earnings before interest & taxes is $38.11 M

What is Kiniksa Pharmaceuticals TTM EBIT year-on-year change?

Over the past year, KNSA TTM earnings before interest & taxes has changed by -$7.01 M (-36.43%)